Eli Lillys oral GLP-1 orforglipron is expected to receive FDA approval in Q2 2026, expanding oral weight loss medication options
However, the FDA has updated its labelling to indicate that Metformin can be used safely in mild and some cases of moderate renal impairment (180)
Note additional factors like energy levels, joint pain, and digestive health these non-scale indicators can provide valuable insights into your progress
Side effect severity correlates strongly with dose escalation speed
Good care starts with discernment, not urgency. Considering Ozempic, Wegovy, Zepbound, or another GLP-1 medication
Drinking alcohol safely Drinking a small amount of alcohol occasionally and on a full stomach is not likely to significantly affect blood glucose levels